-transparent.png){kind=logo}
This paper describes the effect of the selective serotonin reuptake inhibiting drug (SSRI), paroxetine, on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients. 5-Hydroxyindoleacetic acid (5-HIAA), 3-methoxy-4-hydroxyphenylglycol (MHPG) and homovanillic acid (HVA) were measured at baseline and after 3 weeks of treatment with 30 mg paroxetine daily. In line with similar studies on other SSRIs, influence on both the serotonin and noradrenaline metabolite was found. The mechanism behind the action of paroxetine on both 5-HIAA and MHPG is assumed to be an expression of the linkage between the serotonergic and noradrenergic systems in the brain. A frequently reported correlation between 5-HIAA and HVA was also found. The analysis of paroxetine in CSF proves the transportation of the drug into the central nervous system.
J Lundmark, and
J Wålinder, and
C Alling, and
P M Manniche, and
L Dalgaard
May 1991,
Casopis lekaru ceskych,
J Lundmark, and
J Wålinder, and
C Alling, and
P M Manniche, and
L Dalgaard
September 2004,
Biological psychiatry,
J Lundmark, and
J Wålinder, and
C Alling, and
P M Manniche, and
L Dalgaard
January 1991,
Journal of child neurology,
J Lundmark, and
J Wålinder, and
C Alling, and
P M Manniche, and
L Dalgaard
August 1994,
Neuropeptides,
J Lundmark, and
J Wålinder, and
C Alling, and
P M Manniche, and
L Dalgaard
March 1972,
Science (New York, N.Y.),
J Lundmark, and
J Wålinder, and
C Alling, and
P M Manniche, and
L Dalgaard
October 1977,
Life sciences,
J Lundmark, and
J Wålinder, and
C Alling, and
P M Manniche, and
L Dalgaard
February 1974,
Archives of general psychiatry,
J Lundmark, and
J Wålinder, and
C Alling, and
P M Manniche, and
L Dalgaard
August 1988,
American journal of veterinary research,
J Lundmark, and
J Wålinder, and
C Alling, and
P M Manniche, and
L Dalgaard
May 1984,
Minerva medica,
J Lundmark, and
J Wålinder, and
C Alling, and
P M Manniche, and
L Dalgaard
June 2000,
Journal of inherited metabolic disease,
